Translation and validation of European organization for research and treatment of cancer quality of life Questionnaire -C30 into Moroccan version for cancer patients in Morocco

被引:40
|
作者
Nejjari C. [1 ]
El Fakir S. [1 ]
Bendahhou K. [1 ]
El Rhazi K. [1 ]
Abda N. [1 ]
Zidouh A. [2 ]
Benider A. [3 ]
Errihani H. [4 ]
Bekkali R. [2 ]
机构
[1] Department of Epidemiology and Public Health, Faculty of Medicine, University Sidi Mohammed Ben Abdellah, Fez
[2] Fondation Lalla Salma Prevention and Treatment of Cancers, Rabat
[3] Oncology Center Ibn Rochd, Casablanca
[4] National Institute of Oncology, Rabat
关键词
Cancer; Quality of life; Reliability; Validity;
D O I
10.1186/1756-0500-7-228
中图分类号
学科分类号
摘要
Background: Understanding the effects of cancer on the quality of life of affected patients is critical to clinical research as well as to optimal management and care. The aim of this study was to adapt the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30 (EORTC QLQ-C30) questionnaire into Moroccan Arabic and to determine its psychometric properties. After translation, back translation and pretesting of the pre-final version, the translated version was submitted to a committee of professionals composed by oncologists and epidemiologists. The psychometric properties were tested in patients with cancer. Internal consistency was tested using Cronbach's alpha and the test-retest reliability using interclass correlation coefficients. Construct validity was assessed by examining item-convergent and divergent validity. It was also tested using Spearman's correlation between QLQ-C30 scales and EQ-5D. Results: The study was conducted in 125 patients. The Moroccan version was internally reliable, Cronbach'swas 0.87 for the total scale and ranged from 0.34 to 0.97 for the subscales. The intraclass correlation coefficient of the test-retest reliability ranged from 0.64 for "social functioning" to 0.89 for "physical activities" subscales. The instrument demonstrated a good construct and concomitant validity. Conclusions: We have developed a semantically equivalent translation with cultural adaptation of EORTC QLQ-C30 questionnaire. The assessment of its measurement properties showed that it is quite reliable and a valid measure of the effect of cancer on the quality of life in Moroccan patients. © 2014 Nejjari et al.; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 50 条
  • [31] Comparison of two quality-of-life instruments for cancer patients:: The functional assessment of cancer therapy-general and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30
    Kemmler, G
    Holzner, B
    Kopp, M
    Dünser, M
    Margreiter, R
    Greil, R
    Sperner-Unterweger, B
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (09) : 2932 - 2940
  • [32] International cross-cultural field validation of an European Organization for Research and Treatment of Cancer questionnaire module for patients with primary liver cancer, the European Organization for Research and Treatment of Cancer quality-of-life questionnaire HCC18
    Chie, Wei-Chu
    Blazeby, Jane M.
    Hsiao, Chin-Fu
    Chiu, Herng-Chia
    Poon, Ronnie T.
    Mikoshiba, Naoko
    Al-Kadhimi, Gillian
    Heaton, Nigel
    Calara, Jozer
    Collins, Peter
    Caddick, Katharine
    Costantini, Anna
    Vilgrain, Valerie
    Trinquart, Ludovic
    Chiang, Chieh
    HEPATOLOGY, 2012, 55 (04) : 1122 - 1129
  • [33] The European organization for research and treatment of cancer quality of life questionnaire: Implications for prognosis in pancreatic cancer
    Gupta D.
    Lis C.G.
    Grutsch J.F.
    International Journal of Gastrointestinal Cancer, 2006, 37 (2-3): : 65 - 73
  • [34] Which quality of life instruments are preferred by cancer patients in Japan? Comparison of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30 and the Functional Assessment of Cancer Therapy-General
    Kazuki Sato
    Megumi Shimizu
    Mitsunori Miyashita
    Supportive Care in Cancer, 2014, 22 : 3135 - 3141
  • [35] Cross-Cultural Application of the Korean Version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Cervical Cancer Module
    Shin, Dong Wook
    Ahn, Eunmi
    Kim, Yong-Man
    Kang, Sokbom
    Kim, Byoung-Gie
    Seong, Seok Ju
    Do Cha, Soon
    Park, Chan-Yong
    Yun, Young Ho
    ONCOLOGY, 2009, 76 (03) : 190 - 198
  • [36] Which quality of life instruments are preferred by cancer patients in Japan? Comparison of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30 and the Functional Assessment of Cancer Therapy-General
    Sato, Kazuki
    Shimizu, Megumi
    Miyashita, Mitsunori
    SUPPORTIVE CARE IN CANCER, 2014, 22 (12) : 3135 - 3141
  • [37] Validation of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 Summary Score in Patients With Hematologic Malignancies
    Efficace, Fabio
    Cottone, Francesco
    Sommer, Kathrin
    Kieffer, Jacobien
    Aaronson, Neil
    Fayers, Peter
    Groenvold, Mogens
    Caocci, Giovanni
    Lo Coco, Francesco
    Gaidano, Gianluca
    Niscola, Pasquale
    Baccarani, Michele
    Rosti, Gianantonio
    Venditti, Adriano
    Angelucci, Emanuele
    Fazi, Paola
    Vignetti, Marco
    Giesinger, Johannes
    VALUE IN HEALTH, 2019, 22 (11) : 1303 - 1310
  • [38] Deriving a preference-based utility measure for cancer patients from the European Organisation for the Research and Treatment of Cancer's Quality of Life Questionnaire C30: a confirmatory versus exploratory approach
    Costa, Daniel S. J.
    Aaronson, Neil K.
    Fayers, Peter M.
    Grimison, Peter S.
    Janda, Monika
    Pallant, Julie F.
    Rowen, Donna
    Velikova, Galina
    Viney, Rosalie
    Young, Tracey A.
    King, Madeleine T.
    PATIENT-RELATED OUTCOME MEASURES, 2014, 5 : 119 - 129
  • [39] Development and Validation of the Korean Version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire for Patients with Non-muscle Invasive Bladder Cancer: EORTC QLQ-NMIBC24
    Park, Jinsung
    Shin, Dong Wook
    Kim, Tae-Hwan
    Jung, Seung Il
    Nam, Jong Kil
    Park, Seung Chol
    Hong, Sungwoo
    Jung, Jae Hung
    Kim, Hongwook
    Kim, Won Tae
    CANCER RESEARCH AND TREATMENT, 2018, 50 (01): : 40 - 49
  • [40] Translation and validation of European Organization for Research and Treatment for Cancer quality of life questionnaire-OV-28 module into Indian languages (Hindi and Marathi) to study quality of life of ovarian cancer patients from a tertiary care cancer center
    Bajpai, Jyoti
    Panda, Pankaj Kumar
    Kagwade, Shraddha
    Govilkar, Madhavi
    Velaskar, Shruti
    Kembhavi, Yogesh
    Gupta, Sudeep
    Ghosh, Jaya
    Deodhar, Jayita
    SOUTH ASIAN JOURNAL OF CANCER, 2018, 7 (01) : 37 - 41